678 related articles for article (PubMed ID: 23744571)
41. Importance of cerebral artery recanalization in patients with stroke with and without neurological improvement after intravenous thrombolysis.
Kharitonova TV; Melo TP; Andersen G; Egido JA; Castillo J; Wahlgren N;
Stroke; 2013 Sep; 44(9):2513-8. PubMed ID: 23881960
[TBL] [Abstract][Full Text] [Related]
42. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1).
Charidimou A; Pasi M; Fiorelli M; Shams S; von Kummer R; Pantoni L; Rost N
Stroke; 2016 Sep; 47(9):2364-72. PubMed ID: 27491738
[TBL] [Abstract][Full Text] [Related]
43. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy.
Kim DJ; Kim DI; Kim SH; Lee KY; Heo JH; Han SW
Neuroradiology; 2005 Aug; 47(8):616-21. PubMed ID: 15983773
[TBL] [Abstract][Full Text] [Related]
44. Role of tissue plasminogen activator in acute ischemic stroke.
Hatcher MA; Starr JA
Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
[TBL] [Abstract][Full Text] [Related]
45. Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography--guided pilot study.
Sekoranja L; Loulidi J; Yilmaz H; Lovblad K; Temperli P; Comelli M; Sztajzel RF
Stroke; 2006 Jul; 37(7):1805-9. PubMed ID: 16763175
[TBL] [Abstract][Full Text] [Related]
46. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A
Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320
[TBL] [Abstract][Full Text] [Related]
47. Time to recanalization and risk of symptomatic intracerebral haemorrhage in patients treated with intravenous thrombolysis.
Dorado L; Millán M; Pérez de la Ossa N; Guerrero C; Gomis M; Aleu A; López-Cancio E; Cuadras P; Dávalos A
Eur J Neurol; 2012 Sep; 19(9):1251-5. PubMed ID: 22568604
[TBL] [Abstract][Full Text] [Related]
48. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
49. The impact of intracranial carotid artery calcification on the development of thrombolysis-induced intracerebral hemorrhage.
Lin TC; Chao TH; Shieh Y; Lee TH; Chang YJ; Lee JD; Peng TI; Chang KC; Liou CW; Chang TY; Hung KL; Chang CH
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e455-62. PubMed ID: 23800497
[TBL] [Abstract][Full Text] [Related]
50. Comparison of risk-scoring systems in predicting symptomatic intracerebral hemorrhage after intravenous thrombolysis.
Sung SF; Chen SC; Lin HJ; Chen YW; Tseng MC; Chen CH
Stroke; 2013 Jun; 44(6):1561-6. PubMed ID: 23632979
[TBL] [Abstract][Full Text] [Related]
51. Large-Vessel Occlusion Stroke: Effect of Recanalization on Outcome Depends on the National Institutes of Health Stroke Scale Score.
Skagen K; Skjelland M; Russell D; Jacobsen EA
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1532-9. PubMed ID: 25922156
[TBL] [Abstract][Full Text] [Related]
52. Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke.
Messé SR; Pervez MA; Smith EE; Siddique KA; Hellkamp AS; Saver JL; Bhatt DL; Fonarow GC; Peterson ED; Schwamm LH
Stroke; 2013 May; 44(5):1354-9. PubMed ID: 23493734
[TBL] [Abstract][Full Text] [Related]
53. Outcomes of Nonagenarians with Acute Ischemic Stroke Treated with Intravenous Thrombolytics.
Behrouz R; Masjuán-Vallejo J; Vera R; Willey JZ; Zedet M; Moulin S; Cordonnier C; Klijn CJM; Kanselaar K; Dirks M; Silver B; Khan M; Azarpazhooh MR; Godoy DA; Roffe C; Paley L; Bray BD; Smith CJ; Di Napoli M;
J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):246-256. PubMed ID: 28935502
[TBL] [Abstract][Full Text] [Related]
54. Thrombolytic therapy for stroke in patients with preexisting cognitive impairment.
Murao K; Leys D; Jacquin A; Kitazono T; Bordet R; Béjot Y; Kimura K; Godefroy O; Wakisaka Y; Moulin S; Ago T; Sibon I; Bombois S; Mas JL; Hénon H; Pasquier F; Giroud M; Cordonnier C; Okada Y;
Neurology; 2014 Jun; 82(23):2048-54. PubMed ID: 24827495
[TBL] [Abstract][Full Text] [Related]
55. Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.
Mehta RH; Cox M; Smith EE; Xian Y; Bhatt DL; Fonarow GC; Peterson ED;
Stroke; 2014 Aug; 45(8):2263-9. PubMed ID: 25070958
[TBL] [Abstract][Full Text] [Related]
56. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
57. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
[TBL] [Abstract][Full Text] [Related]
58. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.
Mazya M; Egido JA; Ford GA; Lees KR; Mikulik R; Toni D; Wahlgren N; Ahmed N;
Stroke; 2012 Jun; 43(6):1524-31. PubMed ID: 22442178
[TBL] [Abstract][Full Text] [Related]
59. Within-day and weekly variations of thrombolysis in acute ischemic stroke: results from safe implementation of treatments in stroke-international stroke thrombolysis register.
Lorenzano S; Ahmed N; Tatlisumak T; Gomis M; Dávalos A; Mikulik R; Sevcik P; Ollikainen J; Wahlgren N; Toni D;
Stroke; 2014 Jan; 45(1):176-84. PubMed ID: 24262329
[TBL] [Abstract][Full Text] [Related]
60. Standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses.
Liao X; Wang Y; Pan Y; Wang C; Zhao X; Wang DZ; Wang C; Liu L; Wang Y;
Stroke; 2014 Aug; 45(8):2354-8. PubMed ID: 25013020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
